MetaCap

Perrigo Company plc (PRGO)

NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.94-0.10 (-0.62%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PRGO stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$12.47
Dividend yield
7.28% ($1.16)
Ex-dividend date
Aug 28, 2026
52-week range
9.23 – 17.07
Day range
15.53 – 16.40
Volume / Avg
2.18M / 2.54M
Beta
—

52-week range

$9.23$17.07

PRGO stock today

Perrigo (PRGO) closed at $15.94 on Nov 20, down 0.62% (-$0.10), versus the S&P 500's 3.70% decline. At this level, PRGO sits near the top of its 52-week range of $9.23 to $17.07: 6.6% below the high, set on Nov 18, 2026 and 72.7% above the low. PRGO is up 14.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 26.1%.

Perrigo has posted a net loss over the last twelve months (EPS of -$12.47), so its P/E ratio is not meaningful. Perrigo pays an annual dividend of $1.16 per share, a 7.28% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Perrigo

Company profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Albert Ange Manzone
Headquarters
Dublin
Employees
8,100

Financial highlights

Full financials

In fiscal 2025, Perrigo generated $4.25 billion in revenue, down 2.8% from fiscal 2024, its first annual decline since 2024. Perrigo reported a net loss of $1.43 billion, compared with a loss of $171.8 million a year earlier. Gross margin was 35.1% (down from 35.3%) and operating margin -26.4%.

Perrigo annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$4.25B$4.37B$4.66B$4.45B$4.14B
Growth-2.75%-6.06%+4.58%+7.56%+1.24%
Net income$-1.43B$-171.80M$-12.70M$-140.60M$-68.90M
EPS (diluted)$-10.29$-1.25$-0.09$-1.04$-0.52

Analyst forecast

Forecast

Consensus (4 analysts)

buy

Avg. price target

$18.00+12.92%

  • Strong buy 0
  • Buy 1
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $15.00High $20.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$-0.20 vs $0.56
Surprise
-135.71%

Dividends

Dividend history
Annual dividend
$1.16
Last payment
$0.29
Ex-dividend date
Aug 28, 2026

PRGO news

All PRGO news

Perrigo peers

Health Care sector
PRGO peer companies
CompanyPrice% ChgMarket capCompare
PHVSPharvaris N.V.31.28-1.20%$2.21Bvs PRGO
NAMSNewAmsterdam Pharma Company N.V.18.41-5.64%$2.21Bvs PRGO
RCUSArcus Biosciences Inc.15.62-1.01%$2.25Bvs PRGO
LKFTLakefront Biotherapeutics ADR33.31-0.24%$2.18Bvs PRGO
HCMHUTCHMED (China) Limited ADR13.22-1.71%$2.30Bvs PRGO
PBHPrestige Consumer Healthcare Inc.49.63+0.06%$2.35Bvs PRGO
PVLAPalvella Therapeutics Inc.142.85-2.00%$2.09Bvs PRGO
MBXMBX Biosciences Inc.49.55-7.23%$2.46Bvs PRGO

Indexes, lists and sector

Perrigo stock FAQ

What is Perrigo's stock price today?

PRGO last traded at $15.94 as of Nov 20, 4:00 PM EST, down 0.62% on the day. Prices are delayed at least 15 minutes.

Does Perrigo pay a dividend?

Yes. Perrigo pays $1.16 per share annually, a 7.28% yield. The most recent dividend of $0.29 had an ex-dividend date of Aug 28, 2026.

Who is Perrigo's CEO?

Mr. Albert Ange Manzone is the chief executive officer of Perrigo Company plc, which has about 8,100 employees.

Has PRGO ever split its stock?

Yes. The most recent PRGO stock split was a 2-for-1 split on Aug 26, 1993.

What is the PRGO 52-week high?

The 52-week high for PRGO is $17.07 and the 52-week low is $9.23. The stock is currently 6.6% below its high.

Compare PRGO